Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Hydrocortison, ATC H02AB09

AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseEisenberg, GermanyNot disclosed712 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 60%

Complexity: low

712 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Open-house model for non-exclusive rebate contracts (Rabattverträge) for pharmaceutical products containing the active ingredient Hydrocortison (ATC H02AB09) by AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies can join under uniform conditions without a selection procedure. Maximum contract duration 24 months from earliest start 01.08.2026 to 31.07.2028 with continuous enrollment. The first submission deadline for a contract start on 01.08.2026 is 30.06.2026; later monthly deadlines apply. The publication is voluntary and not subject to EU procurement law.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible as contract partners
Submission of signed contract documents and required evidence (e.g., AMIce database extracts)
Submission preferred electronically with qualified electronic signature via email, or in paper (two copies)

Buyer

Name

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse

Location

Eisenberg, DEU

[email protected]

Website

www.aok.de/rheinland-pfalz-saarland/

Buyer profile

Open profile

Identifier

DE271900642

Lots (1)

#LOT-0001Open house Arzneimittelrabattverträge zum Wirkstoff Hydrocortison, ATC H02AB09

Non-exclusive rebate contracts for Hydrocortison pharmaceuticals. Open to all pharmaceutical companies. Contracts have uniform terms, no individual negotiations. Maximum 24 months, with earliest start 01.08.2026. Contracts may be replaced by exclusive contracts awarded through separate tender. Submission can be electronic (with qualified signature) or paper. Initial submission deadline 30.06.2026; later monthly deadlines.

33600000DEU